Soluble Fas - A promising novel urinary marker for the detection of recurrent superficial bladder cancer
Carcinoma, Transitional Cell
Neoplasm Recurrence, Local
Urinary Bladder Neoplasms
sFas was produced and released by bladder TCC cells. Urine sFas was an independent predictor of bladder cancer recurrence and invasiveness in patients who had a past history of nonmuscle invasive bladder TCC, and it outperformed NMP22.